RELAY THERAPEUTICS INC's ticker is RLAY and the CUSIP is 75943R102. A total of 161 filers reported holding RELAY THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.30 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $387,456 | -1.5% | 46,013 | +46.7% | 0.00% | +100.0% |
| Q2 2023 | $393,506 | -12.9% | 31,368 | +14.5% | 0.00% | -50.0% |
| Q1 2023 | $451,590 | -28.3% | 27,394 | -33.5% | 0.00% | +100.0% |
| Q4 2022 | $629,979 | +21.6% | 41,199 | +77.6% | 0.00% | -50.0% |
| Q3 2022 | $518,000 | +14.1% | 23,200 | -14.4% | 0.00% | 0.0% |
| Q2 2022 | $454,000 | +44.1% | 27,102 | +157.7% | 0.00% | +100.0% |
| Q1 2022 | $315,000 | -2.5% | 10,516 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $323,000 | +31.3% | 10,516 | +35.0% | 0.00% | 0.0% |
| Q3 2021 | $246,000 | +15.5% | 7,789 | +33.6% | 0.00% | 0.0% |
| Q2 2021 | $213,000 | +5.4% | 5,830 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $202,000 | -5.6% | 5,830 | +13.4% | 0.00% | 0.0% |
| Q4 2020 | $214,000 | -2.3% | 5,140 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $219,000 | – | 5,140 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 4,530,605 | $135,601,000 | 5.42% |
| Casdin Capital, LLC | 3,857,253 | $115,448,000 | 5.18% |
| Boxer Capital, LLC | 2,669,132 | $79,887,000 | 4.11% |
| Nextech Invest Ltd. | 475,485 | $14,231,000 | 4.06% |
| SB INVESTMENT ADVISERS (UK) LTD | 27,904,963 | $835,196,000 | 3.96% |
| Integral Health Asset Management, LLC | 327,000 | $9,787,000 | 2.55% |
| EcoR1 Capital, LLC | 2,291,441 | $68,583,000 | 2.14% |
| Fernwood Investment Management, LLC | 185,063 | $5,539,000 | 1.94% |
| HARBOURVEST PARTNERS LLC | 296,402 | $8,871,000 | 1.81% |
| HARVARD MANAGEMENT CO INC | 541,124 | $16,196,000 | 1.64% |